title: [Oral osteoporosis: a review and its dental implications].
abstract: In post-menopausal osteoporosis, lack of estrogen will affect the remodeling of the bone tissue in such a way that, in most patients with periodontitis, the amount of bone resorbed exceeds that being formed, resulting in net bone loss. Osteoporosis can be treated by a variety of methods, the hormone replacement therapy (HRT), the selective estrogen receptor modulators (SERM) and the bisphosphonates. The HRT or bisphosphonates treatments improve the clinical outcome of periodontal disease and may be an adjunctive treatment to preserve periodontal bone mass. This paper reviews the current evidence on the mechanism of periodontal breakdown after menopause and the benefit to oral health by treatments for osteoporosis.
authors.affiliation: Aichi-Gakuin University, School of Dentistry, Department of Periodontology.
authors.forename: Koji
authors.initials: K
authors.lastname: Inagaki
authors.forename: Yasunari
authors.initials: Y
authors.lastname: Kurosu
authors.forename: Masahiro
authors.initials: M
authors.lastname: Sakano
authors.forename: Genta
authors.initials: G
authors.lastname: Yamamoto
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kikuchi
authors.forename: Toshihide
authors.initials: T
authors.lastname: Noguchi
authors.forename: Hiroyasu
authors.initials: H
authors.lastname: Yano
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Izawa
authors.forename: Yudo
authors.initials: Y
authors.lastname: Hachiya
mesh_terms: D016301:Alveolar Bone Loss / Q000517:prevention & control*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000172:deficiency / Q000502:physiology; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications* / Q000188:drug therapy*; D010510:Periodontal Diseases / Q000209:etiology* / Q000517:prevention & control; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004967:Estrogens; D020845:Selective Estrogen Receptor Modulators